An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia

NCT01716221 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Friedreich Ataxia

Interventions

DRUG: bupropion & Citalopram
DRUG: Bupropion & Placebo
DRUG: Placebo & Citalopram
DRUG: Placebo & Placebo

Sponsor

University of Colorado, Denver